Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Reversibility of hepatitis C virus-related cirrhosis.

Pol S, Carnot F, Nalpas B, Lagneau JL, Fontaine H, Serpaggi J, Serfaty L, Bedossa P, Bréchot C.

Hum Pathol. 2004 Jan;35(1):107-12.

PMID:
14745732
2.

Review article: predicting response in hepatitis C virus therapy.

Mihm U, Herrmann E, Sarrazin C, Zeuzem S.

Aliment Pharmacol Ther. 2006 Apr 15;23(8):1043-54. Review.

3.

[Treatment of hepatitis C virus-related cirrhosis].

Bronowicki JP.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B220-4. Review. French. No abstract available.

PMID:
12180292
4.

[Kidney transplantation in patients positive for hepatitis C virus].

Campistol JM, Esforzado N, Morales JM, Barrera JM.

Nefrologia. 2002;22 Suppl 5:62-6. Review. Spanish. No abstract available.

5.

[Current treatment of chronic hepatitis B].

Rodríguez M, Pérez R.

Gastroenterol Hepatol. 2001 Feb;24 Suppl 1:51-7. Review. Spanish. No abstract available.

PMID:
11279894
6.

Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background.

Bortolotti F, Guido M.

J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):401-6. Review.

PMID:
17414134
7.

[Organizational characteristics of treatment for chronic hepatitis in Hungary: Hepatitis Registry and Priority Index].

Makara M, Horváth G, Szalay F, Tornai I, Hunyady B.

Orv Hetil. 2013 Jul 21;154(29):1151-5. doi: 10.1556/OH.2013.29671. Review. Hungarian.

PMID:
23853348
8.

Current status in the therapy of liver diseases.

Uhl P, Fricker G, Haberkorn U, Mier W.

Int J Mol Sci. 2014 Apr 30;15(5):7500-12. doi: 10.3390/ijms15057500. Review.

9.

Emerging therapies for liver fibrosis.

Fowell AJ, Iredale JP.

Dig Dis. 2006;24(1-2):174-83. Review.

PMID:
16699275
10.

[Use of pyrogenal in the overall treatment of infectious diseases (a review of the literature)].

Zeĭgermakher GA.

Vrach Delo. 1980 Feb;(2):105-7. Review. Russian. No abstract available.

PMID:
6989111
11.

[Fibrogenesis and liver transplantation].

Benlloch S, Beltrán B, Moreno R, Berenguer M.

Gastroenterol Hepatol. 2003 Jun-Jul;26(6):381-95. Review. Spanish. No abstract available.

PMID:
12809575
12.

[Anti-fibrotic effects of interferons. Mechanisms of action and therapeutic prospects].

Pilette C, Fort J, Rifflet H, Calès P.

Gastroenterol Clin Biol. 1997;21(6-7):466-71. Review. French. No abstract available.

13.

[Interferon in the treatment of viral hepatitis].

Shalmon B, Luria B, Mittelman M.

Harefuah. 1993 Mar 1;124(5):274-7. Review. Hebrew. No abstract available.

PMID:
7684352
14.

[On the reversibility of liver cirrhosis. (Review of the Russian and foreign literature)].

Usov DV.

Klin Khir. 1965 Oct;5:3-7. Review. Russian. No abstract available.

PMID:
5333849

Supplemental Content

Support Center